Asset Management One
TXG icon

Asset Management One’s 10x Genomics TXG Stock Holding History

Asset Management One’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-68,885
Closed -$5.21M – 1068
2022
Q1 		$5.21M Sell
68,885
-1,036
-1% -$90.6K 0.02% 626
2021
Q4 		$10.2M Buy
69,921
+232
+0.3% +$35.5K 0.04% 473
2021
Q3 		$10.2M Sell
69,689
-411
-0.6% -$70.6K 0.04% 469
2021
Q2 		$13.8M Buy
70,100
+4,089
+6% +$740K 0.05% 384
2021
Q1 		$11.7M Buy
66,011
+780
+1% +$135K 0.05% 417
2020
Q4 		$9.28M Buy
65,231
+30,564
+88% +$4.44M 0.04% 461
2020
Q3 		$4.32M Buy
+34,667
New +$3.64M 0.02% 618

Other funds holding TXG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Asset Management One's TXG Position: Q2 2022 in Review

Asset Management One sold out of 10x Genomics (TXG) in Q2 2022, closing a stake of 68,885 shares — an estimated $5.21M sold.

Asset Management One first reported a position in TXG in Q3 2020 and held it in 7 quarters. The position peaked at $13.8M in Q2 2021. 254 funds tracked by Wall St. Rank hold TXG as of Q2 2022.

  • Asset Management One reported no remaining 10x Genomics position as of Q2 2022 after selling out during the quarter.
  • Asset Management One sold 68,885 10x Genomics shares in Q2 2022, an estimated $5.21M.
  • Asset Management One first reported a position in 10x Genomics in Q3 2020 and held it in 7 quarters.
  • Asset Management One's 10x Genomics position peaked at $13.8M in Q2 2021.
  • 254 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2022.

Based on Asset Management One's 13F filing for Q2 2022, filed 29 Jul 2022.